Musculoskeletal/Orthopedics Archives

Musculoskeletal/Orthopedics

Updated guidelines for managing occupational HIV exposure released

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations…

Polymyalgia rheumatica: A possible cause of pericardial effusion

Suspect polymyalgia in patients who continue to decline after treatment for pericardial effusion.

FDA announces recall of Stryker cutting guide for TKA

On April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total knee arthroplasty…

Getting straight on low back pain treatment

Be sure you’re up to date on this common problem.

Study: Even minor increases in physical activity benefits bone health in premenopausal women

A study to be published in the Journal of Clinical Endocrinology and Metabolism found that physical activity, even minor increases, in premenopausal women is…

Precision and perfection

Our Editor-in-Chief tells the story of her experience as a patient.

FDA seeks advice on metal-on-metal hip replacements

On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…

FDA approves first generic versions of Boniva

On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat osteoporosis. Read…

Use of bone morhphogenetic proteins not associated less reoperation for lumbar stenosis

A study in February’s Spine reports that use of bone morhphogenetic proteins (BMP) in spinal fusion surgery for older adults with lumbar stenosis reports…

Are you ready to care for patients in clinical trials?

Part 1 of a four-part series on clinical trials

NEJM study assess BMD retesting

A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with normal bone…

FDA approves first drug for myelofibrosis

The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read…

Updated guidelines for managing occupational HIV exposure released

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus…

Polymyalgia rheumatica: A possible cause of pericardial effusion

Suspect polymyalgia in patients who continue to decline after treatment for pericardial effusion.

FDA announces recall of Stryker cutting guide for TKA

On April 19, the U.S. Food and Drug Administration (FDA) announced that Stryker Orthopaedics has recalled ShapeMatch Cutting Guides, used in total…

Getting straight on low back pain treatment

Be sure you’re up to date on this common problem.

Study: Even minor increases in physical activity benefits bone health in premenopausal women

A study to be published in the Journal of Clinical Endocrinology and Metabolism found that physical activity, even minor increases, in premenopausal…

Precision and perfection

Our Editor-in-Chief tells the story of her experience as a patient.

FDA seeks advice on metal-on-metal hip replacements

On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…

FDA approves first generic versions of Boniva

On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat…

Use of bone morhphogenetic proteins not associated less reoperation for lumbar stenosis

A study in February’s Spine reports that use of bone morhphogenetic proteins (BMP) in spinal fusion surgery for older adults with lumbar…

Are you ready to care for patients in clinical trials?

Part 1 of a four-part series on clinical trials

NEJM study assess BMD retesting

A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with…

FDA approves first drug for myelofibrosis

The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease…

Musculoskeletal/Orthopedics

Test Your Knowledge

NurseLine Newsletter

About

Contact

Podcasts